Drug Type Small molecule drug |
Synonyms (3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine, (E)-metanicotine, (E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine + [6] |
Target |
Mechanism Nicotinic receptors agonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H14N2 |
InChIKeyJUOSGGQXEBBCJB-GORDUTHDSA-N |
CAS Registry15585-43-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08987 | Rivanicline | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | - | - | |
Colitis, Ulcerative | Phase 2 | - | - |